BAG4

BAG4 (also known as SODD) is a multifunctional co-chaperone and signaling regulator that suppresses death receptor signaling, sustains PI3K/Akt and MAPK pathway activity, and modulates mitophagy. Its BAG domain adopts a minimal three-helix bundle that binds Hsc70/Hsp70 to modulate chaperone function, while its constitutive association with the TNFR1 death domain prevents spontaneous receptor activation; SODD-deficient mice show accelerated TNF-induced NF-κB signaling and elevated cytokine production, confirming its role as a negative regulator of the inflammatory arm of TNFR1 (PMID:12058034, PMID:12748303). BAG4 also inhibits the PI(3,4,5)P3 5-phosphatase SKIP, thereby sustaining Akt phosphorylation, actin remodeling, and cell migration, and separately binds RAF-1 to promote MEK/ERK pathway activation (PMID:21712384, PMID:37107587). During mycobacterial infection, bacterial PknG phosphorylates BAG4 at Thr405, locking it onto TNFR1 to block Caspase-8-mediated apoptosis, while USP14-mediated K48 deubiquitination at K403 stabilizes BAG4 protein to inhibit Parkin-dependent mitophagy in colorectal cancer cells (PMID:40035756, PMID:40316942).

1. 2002 High

   Solving the BAG4 BAG domain structure revealed it as the minimal Hsc70-binding module—shorter than BAG1 by one-third—establishing BAG4 as a bona fide co-chaperone with a structurally distinct domain architecture.

   Evidence Multidimensional NMR solution structure with Hsc70 binding validation

   PMID:12058034

   Open questions at the time

   • No crystal structure of the BAG4–Hsc70 complex exists
   • Functional consequence of the shorter BAG domain for substrate refolding is undefined
2. 2003 High

   Genetic ablation of SODD in mice demonstrated that its primary signaling role is to dampen the NF-κB inflammatory arm of TNFR1 rather than the apoptotic arm, resolving ambiguity from earlier overexpression studies.

   Evidence SODD knockout mice with ex vivo macrophage and MEF signaling assays for NF-κB, JNK, and apoptosis

   PMID:12748303

   Open questions at the time

   • Mechanism by which SODD selectively attenuates NF-κB but not apoptotic signaling from TNFR1 is unclear
   • Physiological consequences of SODD loss under chronic inflammatory challenge remain uncharacterized
3. 2003 Medium

   Overexpression studies extended SODD's protective function beyond TNFR1 to CD95-mediated death signaling, broadening its role as a general suppressor of death-receptor-induced cytotoxicity.

   Evidence Stable BAG4 overexpression in HeLa cells with TNFα and CD95L cytotoxicity assays

   PMID:12706861

   Open questions at the time

   • Direct binding of SODD to CD95 was not demonstrated
   • No loss-of-function validation for the CD95 pathway
4. 2005 Medium

   Discovery that BAG4 colocalizes with Hsp70 on the plasma membrane and that its overexpression elevates membrane Hsp70 linked the co-chaperone function to a membrane-associated protective phenotype against radiation.

   Evidence Two-parameter flow cytometry, co-IP of BAG4–Hsp70, stable overexpression with radiation survival assays

   PMID:15592361

   Open questions at the time

   • Mechanism by which BAG4 increases membrane Hsp70 is unknown
   • Radiation protection was shown only by overexpression, not loss-of-function
5. 2011 High

   Identification of SKIP as a direct BAG4-binding partner whose 5-phosphatase activity is inhibited by BAG4 revealed an unexpected role in sustaining PI3K/Akt signaling, actin remodeling, and cell migration independent of death receptor biology.

   Evidence Co-IP, in vitro phosphatase activity assay, SODD-KO MEFs with Akt phosphorylation, F-actin imaging, migration assays, constitutively active Akt rescue

   PMID:21712384

   Open questions at the time

   • Structural basis of BAG4–SKIP interaction is unknown
   • Whether the BAG domain or another region mediates SKIP inhibition is unresolved
6. 2023 Medium

   BAG4 was shown to bind RAF-1 and promote PDK1/AKT and RAF/MEK/ERK pathway activation in lung cancer, extending its pro-survival signaling role to MAPK cascades and linking it to tumor growth in vivo.

   Evidence CRISPR/Cas9 knockout in lung cancer cells, co-IP of BAG4–RAF-1, xenograft tumor model

   PMID:37107587

   Open questions at the time

   • Direct versus indirect nature of BAG4–RAF-1 binding not resolved
   • Relationship between the SKIP-inhibition and RAF-1-binding functions of BAG4 is unexplored
7. 2025 High

   Mycobacterial PknG-mediated phosphorylation of host SODD at Thr405 was found to lock SODD onto TNFR1, blocking Caspase-8 activation, revealing a pathogen hijacking mechanism that converts SODD from a tunable regulator to an irreversible death-receptor silencer.

   Evidence Phosphoproteomics, PknG Cys109 mutagenesis, PknG-KO M. tuberculosis infection, Caspase-8 assay, co-IP of phospho-SODD–TNFR1

   PMID:40035756

   Open questions at the time

   • Structural basis for how Thr405 phosphorylation converts reversible to irreversible TNFR1 binding is unknown
   • Whether host kinases also phosphorylate Thr405 under sterile conditions is untested
8. 2025 Medium

   USP14 was identified as the deubiquitinase that removes K48-linked ubiquitin from BAG4 at K403, stabilizing BAG4 protein and thereby blocking Parkin recruitment and mitophagy, adding post-translational control of BAG4 turnover as a regulatory layer.

   Evidence DUB siRNA library screen, co-IP, ubiquitination assays, mitophagy assays, xenograft model in MSI-high CRC cells

   PMID:40316942

   Open questions at the time

   • E3 ligase responsible for K48-ubiquitination of BAG4 is not identified
   • Domain of BAG4 through which it blocks Parkin recruitment is unknown
   • Single-lab finding awaiting independent confirmation

• A unified structural and mechanistic model explaining how BAG4 simultaneously engages Hsc70, TNFR1, SKIP, and RAF-1—and whether these interactions are mutually exclusive or occur in distinct pools—remains unresolved.
• No full-length BAG4 structure or multi-partner complex structure exists
• Domain mapping for SKIP and RAF-1 binding has not been performed
• In vivo relevance of BAG4's mitophagy-regulatory role outside colorectal cancer is unknown